NEW YORK, Oct. 7 (GenomeWeb news) - Gene Logic said today that it has signed a co-licensing agreement with Biogen Idec under which it will provide genomic services using Biogen Idec's proprietary non-human primate microarray. In turn, Gene Logic will grant Biogen a one-year subscription to its ToxExpress System and ToxShield services.
Biogen Idec's NHP Affymetrix GeneChip microarray includes "a comprehensive representation" of the genome of the cytomolgus monkey, as well as a "comparable cohort" of rhesus genes, Gene Logic said in a statement. The 11-micron array includes more than 51,000 probe sets.
Gene Logic said it expects the microarray will "aid in identifying drug targets and biomarkers, assessing drug toxicity, and prioritizing drug candidates."
Gene Logic will have exclusive access to the array for three years, according to the statement.
Biogen Idec will use the ToxExpress System to assess the potential toxicity of its proprietary drug candidates and will use the ToxShield Suite for "assessing and rank-ordering drug candidates based on potential toxicity in humans."